Takeda Can't Duck Generic-Drug Delay Suit At 2nd Circ.
By Bryan Koenig · August 25, 2021, 6:51 PM EDT
The Second Circuit found on Wednesday that Takeda cannot upend a New York federal judge's decision to preserve antitrust claims that it delayed entry of generic alternatives to diabetes treatment Actos,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login